Related Experiment Video
Updated: May 1, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Optimal control for predicting customized drug dosage for superovulation stage of in vitro fertilization
Kirti M Yenkie1, Urmila Diwekar1
1The Richard and Loan Hill Department of Bioengineering, University of Illinois, Chicago, IL 60607, USA; Center for Uncertain Systems: Tools for Optimization & Management (CUSTOM), Vishwamitra Research Institute, Clarendon Hills, IL 60514, USA.
Abstract:
in vitro fertilization (IVF) is one of the most highly pursued assisted reproductive technologies (ART) worldwide. IVF procedure is divided into four stages: Superovulation, Egg-retrieval, Insemination/Fertilization and Embryo transfer. Among these superovulation is the most crucial stage since it involves external injection of hormones to stimulate development and maturation of multiple follicles or oocytes. Although numerous advancements have been made in IVF procedures, little attention has been given to modifying the existing protocols based on a 'patient specific' predictive model. A model for follicle growth and number change as a function of the injected hormones and patient characteristics has been developed and validated for data available on 50 superovulation cycles. The model has 9 patient specific parameters which can be determined from the initial 2 days of observation and can help in projecting the superovulation outcome for the ongoing cycle. Based on this model, the dosage of the hormones to stimulate multiple ovulation or follicle growth is predicted by using the theory of optimal control. The objective of successful superovulation is to obtain maximum number of mature oocytes/follicles within a particular size range. Using the mathematical model of follicle growth dynamics and optimal control theory, optimal dose and frequency of medication customized for each patient (n=5) is predicted for obtaining the desired result. The results indicate a better final day follicle size distribution when the dosage of the hormones is varied by some amounts as compared to the actual dosage given to the patient in the existing cycles. This ensures a better success rate for the superovulation cycles and reduces the costs of excess medication and daily monitoring. The idea is to provide the medical practitioners with a guideline for planned treatment, for a procedure currently based on trial and error in order to get better success rates.
Related Concept Videos
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
In Vitro Fertilization
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Dosage Regimens: Designs and Approaches
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...

